EP 1373219 A1 20040102 - THIOHYDANTOINS AND USE THEREOF FOR TREATING DIABETES
Title (en)
THIOHYDANTOINS AND USE THEREOF FOR TREATING DIABETES
Title (de)
THIOHYDANTOINE UND DEREN VERWENDUNG ZUR BEHANDLUNG VON DIABETES
Title (fr)
THIOHYDANTOINES ET LEUR UTILISATION DANS LE TRAITEMENT DU DIABETE
Publication
Application
Priority
- FR 0201167 W 20020404
- FR 0104552 A 20010404
Abstract (en)
[origin: WO02081453A1] The invention concerns compounds derived from 2-thiohydantoin selected among compounds of general formula (I), such as defined in the claims, and their addition salts with an acid, in particular pharmaceutically acceptable salts. The invention also concerns the method for preparing same, pharmaceutical compositions containing them and their use as pharmacologically active substance, in particular for treating diabetes, diseases mediated by hyperglycemia, hypertriglyceridemiae, dyslipidaemiae or obesity.
IPC 1-7
IPC 8 full level
A61K 31/4178 (2006.01); A61K 31/438 (2006.01); A61K 31/454 (2006.01); A61K 31/46 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 31/538 (2006.01); A61K 31/541 (2006.01); A61K 31/55 (2006.01); A61K 31/551 (2006.01); A61K 31/553 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 9/10 (2006.01); C07D 233/86 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 403/10 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 405/04 (2006.01); C07D 405/06 (2006.01); C07D 405/10 (2006.01); C07D 407/04 (2006.01); C07D 409/04 (2006.01); C07D 413/04 (2006.01); C07D 413/10 (2006.01); C07D 413/14 (2006.01); C07D 451/06 (2006.01); C07D 491/10 (2006.01)
CPC (source: EP KR US)
A61P 3/04 (2018.01 - EP); A61P 3/06 (2018.01 - EP); A61P 3/10 (2018.01 - EP); A61P 9/10 (2018.01 - EP); C07D 233/86 (2013.01 - EP US); C07D 401/04 (2013.01 - EP US); C07D 401/06 (2013.01 - EP US); C07D 401/10 (2013.01 - EP US); C07D 401/12 (2013.01 - EP US); C07D 401/14 (2013.01 - EP US); C07D 403/04 (2013.01 - EP US); C07D 403/10 (2013.01 - EP US); C07D 403/12 (2013.01 - EP US); C07D 405/04 (2013.01 - EP US); C07D 405/06 (2013.01 - EP US); C07D 409/04 (2013.01 - EP US); C07D 413/04 (2013.01 - EP US); C07D 413/10 (2013.01 - KR); C07D 491/10 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02081453 A1 20021017; WO 02081453 A8 20021114; BG 108225 A 20050430; BR 0207910 A 20040803; CA 2444024 A1 20021017; CN 1500081 A 20040526; CZ 20032696 A3 20031217; EE 200300485 A 20040216; EP 1373219 A1 20040102; FR 2823209 A1 20021011; FR 2823209 B1 20031212; HU P0401537 A2 20050128; HU P0401537 A3 20050628; IL 158195 A0 20040328; JP 2004525175 A 20040819; KR 20030085565 A 20031105; MX PA03009083 A 20041122; NO 20034430 D0 20031003; NO 20034430 L 20031006; PL 364904 A1 20041227; RU 2003129532 A 20050410; SK 12332003 A3 20040406; US 2004116417 A1 20040617; YU 75903 A 20060525; ZA 200307372 B 20040922
DOCDB simple family (application)
FR 0201167 W 20020404; BG 10822503 A 20031003; BR 0207910 A 20020404; CA 2444024 A 20020404; CN 02807581 A 20020404; CZ 20032696 A 20020404; EE P200300485 A 20020404; EP 02730333 A 20020404; FR 0104552 A 20010404; HU P0401537 A 20020404; IL 15819502 A 20020404; JP 2002579441 A 20020404; KR 20037012356 A 20030922; MX PA03009083 A 20020404; NO 20034430 A 20031003; PL 36490402 A 20020404; RU 2003129532 A 20020404; SK 12332003 A 20020404; US 47303203 A 20030926; YU P75903 A 20020404; ZA 200307372 A 20030922